rs3918143

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005104.4(BRD2):​c.1421C>T​(p.Ala474Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0308 in 1,613,002 control chromosomes in the GnomAD database, including 859 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.024 ( 63 hom., cov: 32)
Exomes 𝑓: 0.031 ( 796 hom. )

Consequence

BRD2
NM_005104.4 missense

Scores

1
17

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.50

Publications

23 publications found
Variant links:
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005104.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033878982).
BP6
Variant 6-32977848-C-T is Benign according to our data. Variant chr6-32977848-C-T is described in ClinVar as Benign. ClinVar VariationId is 3055955.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0236 (3597/152196) while in subpopulation SAS AF = 0.0388 (187/4818). AF 95% confidence interval is 0.0343. There are 63 homozygotes in GnomAd4. There are 1720 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005104.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRD2
NM_005104.4
MANE Select
c.1421C>Tp.Ala474Val
missense
Exon 9 of 13NP_005095.1P25440-1
BRD2
NM_001199455.1
c.1421C>Tp.Ala474Val
missense
Exon 8 of 13NP_001186384.1P25440-2
BRD2
NM_001113182.3
c.1421C>Tp.Ala474Val
missense
Exon 9 of 13NP_001106653.1P25440-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRD2
ENST00000374825.9
TSL:1 MANE Select
c.1421C>Tp.Ala474Val
missense
Exon 9 of 13ENSP00000363958.4P25440-1
BRD2
ENST00000395287.5
TSL:1
c.1421C>Tp.Ala474Val
missense
Exon 8 of 13ENSP00000378702.1P25440-2
BRD2
ENST00000449025.5
TSL:1
c.1436C>Tp.Ala479Val
missense
Exon 8 of 12ENSP00000409613.1H0Y6K2

Frequencies

GnomAD3 genomes
AF:
0.0237
AC:
3597
AN:
152078
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00647
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0244
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.0247
Gnomad SAS
AF:
0.0384
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.0351
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0293
AC:
7213
AN:
246574
AF XY:
0.0305
show subpopulations
Gnomad AFR exome
AF:
0.00662
Gnomad AMR exome
AF:
0.0251
Gnomad ASJ exome
AF:
0.0130
Gnomad EAS exome
AF:
0.0240
Gnomad FIN exome
AF:
0.0135
Gnomad NFE exome
AF:
0.0348
Gnomad OTH exome
AF:
0.0344
GnomAD4 exome
AF:
0.0315
AC:
46009
AN:
1460806
Hom.:
796
Cov.:
63
AF XY:
0.0321
AC XY:
23328
AN XY:
726720
show subpopulations
African (AFR)
AF:
0.00484
AC:
162
AN:
33480
American (AMR)
AF:
0.0255
AC:
1139
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0131
AC:
343
AN:
26136
East Asian (EAS)
AF:
0.0161
AC:
641
AN:
39700
South Asian (SAS)
AF:
0.0447
AC:
3853
AN:
86258
European-Finnish (FIN)
AF:
0.0151
AC:
791
AN:
52348
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5768
European-Non Finnish (NFE)
AF:
0.0335
AC:
37305
AN:
1112006
Other (OTH)
AF:
0.0284
AC:
1714
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2850
5700
8551
11401
14251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1386
2772
4158
5544
6930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0236
AC:
3597
AN:
152196
Hom.:
63
Cov.:
32
AF XY:
0.0231
AC XY:
1720
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00645
AC:
268
AN:
41528
American (AMR)
AF:
0.0243
AC:
372
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3466
East Asian (EAS)
AF:
0.0245
AC:
127
AN:
5174
South Asian (SAS)
AF:
0.0388
AC:
187
AN:
4818
European-Finnish (FIN)
AF:
0.0141
AC:
149
AN:
10602
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.0351
AC:
2385
AN:
67992
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
179
359
538
718
897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0311
Hom.:
342
Bravo
AF:
0.0233
Asia WGS
AF:
0.0480
AC:
169
AN:
3478
EpiCase
AF:
0.0328
EpiControl
AF:
0.0344

ClinVar

ClinVar submissions
Significance:Benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
BRD2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
20
DANN
Benign
0.87
DEOGEN2
Benign
0.070
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.49
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.5
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-0.28
N
REVEL
Benign
0.080
Sift
Benign
0.26
T
Sift4G
Benign
0.41
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.057
gMVP
0.17
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3918143;
hg19: chr6-32945625;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.